Penumbra, Inc Cost of Revenue
Penumbra, Inc (PEN) reported Cost of Revenue of $125.10 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Expense Statement
us-gaap:CostOfRevenue · last filed 2026-07-30
- Penumbra, Inc cost of revenue for the quarter ending 2026-06-30 was $125.10M, a 8.37% increase year-over-year.
- Penumbra, Inc cost of revenue for the quarter ending 2026-03-31 was $121.35M, a 12.09% increase year-over-year.
- Penumbra, Inc cost of revenue for the quarter ending 2025-12-31 was $123.26M, a 17.62% increase year-over-year.
- Penumbra, Inc cost of revenue for the quarter ending 2025-09-30 was $114.27M, a 13.44% increase year-over-year.
- Penumbra, Inc cost of revenue for fiscal 2025 was $461.23M, a 4.92% increase from fiscal 2024.
- Penumbra, Inc cost of revenue for fiscal 2024 was $439.62M, a 16.96% increase from fiscal 2023.
- Penumbra, Inc cost of revenue for fiscal 2023 was $375.88M, a 20.50% increase from fiscal 2022.
- Penumbra, Inc cost of revenue for fiscal 2022 was $311.93M, a 14.59% increase from fiscal 2021.
| Period end | Cost of Revenue 3 month | Cost of Revenue 6 month | Cost of Revenue 9 month | Cost of Revenue 12 month |
|---|---|---|---|---|
| 2026-06-30 | $125.10M 10-Q · filed 2026-07-30 | $246.45M 10-Q · filed 2026-07-30 | $369.71M derived: sum of 3 quarters · filed 2026-07-30 | $483.98M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $121.35M 10-Q · filed 2026-05-06 | $244.60M derived: sum of 2 quarters · filed 2026-05-06 | $358.87M derived: sum of 3 quarters · filed 2026-05-06 | $474.32M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $123.26M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $237.53M derived: sum of 2 quarters · filed 2026-02-25 | $352.97M derived: sum of 3 quarters · filed 2026-07-30 | $461.23M 10-K · filed 2026-02-25 |
| 2025-09-30 | $114.27M 10-Q · filed 2025-11-05 | $229.71M derived: sum of 2 quarters · filed 2026-07-30 | $337.97M 10-Q · filed 2025-11-05 | $442.77M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $115.44M 10-Q · filed 2026-07-30 | $223.70M 10-Q · filed 2026-07-30 | $328.50M derived: sum of 3 quarters · filed 2026-07-30 | $429.23M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $108.26M 10-Q · filed 2026-05-06 | $213.05M derived: sum of 2 quarters · filed 2026-05-06 | $313.79M derived: sum of 3 quarters · filed 2026-05-06 | $450.36M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $104.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $205.53M derived: sum of 2 quarters · filed 2026-02-25 | $342.10M derived: sum of 3 quarters · filed 2026-02-25 | $439.62M 10-K · filed 2026-02-25 |
| 2024-09-30 | $100.73M 10-Q · filed 2025-11-05 | $237.31M derived: sum of 2 quarters · filed 2025-11-05 | $334.82M 10-Q · filed 2025-11-05 | $432.51M derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | $136.57M 10-Q · filed 2025-07-29 | $234.09M 10-Q · filed 2025-07-29 | $331.78M derived: sum of 3 quarters · filed 2025-07-29 | $425.00M derived: sum of 4 quarters · filed 2025-07-29 |
| 2024-03-31 | $97.52M 10-Q · filed 2025-04-23 | $195.20M derived: sum of 2 quarters · filed 2025-04-23 | $288.43M derived: sum of 3 quarters · filed 2025-04-23 | $383.07M derived: sum of 4 quarters · filed 2025-04-23 |
| 2023-12-31 | $97.69M 10-K · filed 2024-02-22 | $190.91M derived: sum of 2 quarters · filed 2024-10-30 | $285.55M derived: sum of 3 quarters · filed 2024-10-30 | $375.88M 10-K · filed 2026-02-25 |
| 2023-09-30 | $93.23M 10-Q · filed 2024-10-30 | $187.87M derived: sum of 2 quarters · filed 2024-10-30 | $278.19M 10-Q · filed 2024-10-30 | $360.98M derived: sum of 4 quarters · filed 2024-10-30 |
| 2023-06-30 | $94.64M 10-Q · filed 2024-07-30 | $184.96M 10-Q · filed 2024-07-30 | $267.75M derived: sum of 3 quarters · filed 2024-07-30 | $346.10M derived: sum of 4 quarters · filed 2024-07-30 |
| 2023-03-31 | $90.33M 10-Q · filed 2024-05-07 | $173.12M derived: sum of 2 quarters · filed 2024-05-07 | $251.47M derived: sum of 3 quarters · filed 2024-05-07 | $325.77M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $82.79M 10-K · filed 2024-02-22 | $161.14M derived: sum of 2 quarters · filed 2024-02-22 | $235.45M derived: sum of 3 quarters · filed 2024-02-22 | $311.93M 10-K · filed 2025-02-18 |
| 2022-09-30 | $78.35M 10-K · filed 2024-02-22 | $152.66M derived: sum of 2 quarters · filed 2024-02-22 | $229.14M 10-Q · filed 2023-11-02 | $307.70M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $74.31M 10-K · filed 2024-02-22 | $150.79M 10-Q · filed 2023-08-01 | $229.35M derived: sum of 3 quarters · filed 2024-02-22 | $299.56M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $76.48M 10-K · filed 2024-02-22 | $155.04M derived: sum of 2 quarters · filed 2024-02-22 | $225.25M derived: sum of 3 quarters · filed 2024-02-22 | $290.82M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $78.56M 10-K · filed 2023-02-23 | $148.77M derived: sum of 2 quarters · filed 2023-02-23 | $214.34M derived: sum of 3 quarters · filed 2023-02-23 | $272.21M 10-K · filed 2024-02-22 |
| 2021-09-30 | $70.20M 10-K · filed 2023-02-23 | $135.78M derived: sum of 2 quarters · filed 2023-02-23 | $193.64M 10-Q · filed 2022-11-03 | $266.23M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $65.57M 10-K · filed 2023-02-23 | $123.44M 10-Q · filed 2022-08-05 | $196.02M derived: sum of 3 quarters · filed 2023-02-23 | $256.18M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $57.87M 10-K · filed 2023-02-23 | $130.45M derived: sum of 2 quarters · filed 2023-02-23 | $190.60M derived: sum of 3 quarters · filed 2023-02-23 | $230.78M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $72.58M 10-K · filed 2022-02-22 | $132.74M derived: sum of 2 quarters · filed 2022-02-22 | $172.92M derived: sum of 3 quarters · filed 2022-02-22 | $222.24M 10-K · filed 2023-02-23 |
| 2020-09-30 | $60.15M 10-K · filed 2022-02-22 | $100.33M derived: sum of 2 quarters · filed 2022-02-22 | $149.65M 10-Q · filed 2021-11-03 | $196.79M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-06-30 | $40.18M 10-K · filed 2022-02-22 | $89.50M 10-Q · filed 2021-08-09 | $136.63M derived: sum of 3 quarters · filed 2022-02-22 | $180.14M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-03-31 | $49.32M 10-K · filed 2022-02-22 | $96.45M derived: sum of 2 quarters · filed 2022-02-22 | $139.96M derived: sum of 3 quarters · filed 2022-02-22 | $180.23M derived: sum of 4 quarters · filed 2022-02-22 |
| 2019-12-31 | $47.13M 10-K · filed 2021-02-23 | $90.64M derived: sum of 2 quarters · filed 2021-02-23 | $130.91M derived: sum of 3 quarters · filed 2021-02-23 | $175.44M 10-K · filed 2022-02-22 |
| 2019-09-30 | $43.50M 10-K · filed 2021-02-23 | $83.78M derived: sum of 2 quarters · filed 2021-02-23 | $128.31M 10-Q · filed 2020-11-02 | $170.39M derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-06-30 | $40.27M 10-K · filed 2021-02-23 | $84.80M 10-Q · filed 2020-08-03 | $126.88M derived: sum of 3 quarters · filed 2021-02-23 | $163.68M derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-03-31 | $44.53M 10-K · filed 2021-02-23 | $86.61M derived: sum of 2 quarters · filed 2021-02-23 | $123.40M derived: sum of 3 quarters · filed 2021-02-23 | $160.79M derived: sum of 4 quarters · filed 2021-02-23 |
| 2018-12-31 | $42.08M 10-K · filed 2020-02-26 | $78.88M derived: sum of 2 quarters · filed 2020-02-26 | $116.26M derived: sum of 3 quarters · filed 2020-02-26 | $152.41M 10-K · filed 2021-02-23 |
| 2018-09-30 | $36.79M 10-K · filed 2020-02-26 | $74.18M derived: sum of 2 quarters · filed 2020-02-26 | $110.32M 10-Q · filed 2019-11-07 | $142.65M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-06-30 | $37.39M 10-K · filed 2020-02-26 | $73.53M 10-Q · filed 2019-08-06 | $105.85M derived: sum of 3 quarters · filed 2020-02-26 | $134.99M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-03-31 | $36.14M 10-K · filed 2020-02-26 | $68.47M derived: sum of 2 quarters · filed 2020-02-26 | $97.60M derived: sum of 3 quarters · filed 2020-02-26 | $127.26M derived: sum of 4 quarters · filed 2020-02-26 |
| 2017-12-31 | $32.32M 10-K · filed 2019-02-26 | $61.46M derived: sum of 2 quarters · filed 2019-02-26 | $91.12M derived: sum of 3 quarters · filed 2019-02-26 | $116.62M 10-K · filed 2020-02-26 |
| 2017-09-30 | $29.13M 10-K · filed 2019-02-26 | $58.79M derived: sum of 2 quarters · filed 2019-02-26 | $84.30M 10-Q · filed 2018-11-05 | $110.82M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | $29.66M 10-K · filed 2019-02-26 | $55.16M 10-Q · filed 2018-08-07 | $81.69M derived: sum of 3 quarters · filed 2019-02-26 | $106.00M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | $25.50M 10-K · filed 2019-02-26 | $52.03M derived: sum of 2 quarters · filed 2019-02-26 | $76.34M derived: sum of 3 quarters · filed 2019-02-26 | $99.98M derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | $26.52M 10-K · filed 2018-02-27 | $50.84M derived: sum of 2 quarters · filed 2018-02-27 | $74.47M derived: sum of 3 quarters · filed 2018-02-27 | $92.49M 10-K · filed 2019-02-26 |
| 2016-09-30 | $24.31M 10-K · filed 2018-02-27 | $47.95M derived: sum of 2 quarters · filed 2018-02-27 | $65.96M 10-Q · filed 2017-11-07 | $83.92M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $23.64M 10-K · filed 2018-02-27 | $41.65M 10-Q · filed 2017-08-08 | $59.61M derived: sum of 3 quarters · filed 2018-02-27 | $76.53M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $18.01M 10-K · filed 2018-02-27 | $35.97M derived: sum of 2 quarters · filed 2018-02-27 | $52.89M derived: sum of 3 quarters · filed 2018-02-27 | $67.83M derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | $17.96M 10-K · filed 2017-02-28 | $34.88M derived: sum of 2 quarters · filed 2017-02-28 | $49.81M derived: sum of 3 quarters · filed 2017-02-28 | $62.04M 10-K · filed 2018-02-27 |
| 2015-09-30 | $16.92M 10-K · filed 2017-02-28 | $31.86M derived: sum of 2 quarters · filed 2017-02-28 | $44.08M 10-Q · filed 2016-11-03 | $55.59M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-06-30 | $14.94M 10-K · filed 2017-02-28 | $27.16M 10-Q · filed 2016-08-09 | $38.67M derived: sum of 3 quarters · filed 2017-02-28 | $50.34M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-03-31 | $12.22M 10-K · filed 2017-02-28 | $23.74M derived: sum of 2 quarters · filed 2017-02-28 | $35.40M derived: sum of 3 quarters · filed 2017-02-28 | $46.18M derived: sum of 4 quarters · filed 2017-02-28 |
| 2014-12-31 | $11.51M 10-K · filed 2016-03-08 | $23.18M derived: sum of 2 quarters · filed 2016-03-08 | $33.96M derived: sum of 3 quarters · filed 2016-03-08 | $42.67M 10-K · filed 2017-02-28 |
| 2014-09-30 | $11.67M 10-K · filed 2016-03-08 | $22.45M derived: sum of 2 quarters · filed 2016-03-08 | $31.16M 10-Q · filed 2015-11-12 | |
| 2014-06-30 | $10.78M 10-K · filed 2016-03-08 | $19.49M derived: sum of 2 quarters · filed 2016-03-08 | ||
| 2014-03-31 | $8.71M 10-K · filed 2016-03-08 | |||
| 2013-12-31 | $30.97M 10-K · filed 2016-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |